Salinomycin exerts anti-angiogenic and anti-tumorigenic activities by inhibiting vascular endothelial growth factor receptor 2-mediated angiogenesis

Anti-angiogenesis targeting VEGFR2 has been an attractive strategy for cancer therapy for its role in promoting cancer growth and metastasis. However, the currently available drugs have unexpected side effects. Therefore, development of novel VEGFR2 inhibitors with less toxicity would be of great va...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Oncotarget
Hoofdauteurs: Li, Tao, Liu, Xiaoxia, Shen, Qin, Yang, Wenjun, Huo, Zhenghao, Liu, Qilun, Jiao, Haiyan, Chen, Jing
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Impact Journals LLC 2016
Onderwerpen:
Research Paper
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5042000/
https://ncbi.nlm.nih.gov/pubmed/27058891
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.8555
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items